Skip to content

TAMIR BIOTECHNOLOGY, INC.: 10-Q filed 2013-05-07

What TAMIR BIOTECHNOLOGY, INC. reported in its quarterly report filed 2013-05-07 (fiscal Q1 2012): 30 published measures, 64 facts as tagged in accession 0001308411-13-000123.

This filing

Form
10-Q (quarterly report)
Filed
2013-05-07
Fiscal period
fiscal Q1 2012
Accession
0001308411-13-000123 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All TAMIR BIOTECHNOLOGY, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-10-31281,212USD
At 2011-07-31521,513USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-10-316,542,816USD
At 2011-07-318,618,440USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-10-31-6,261,604USD
At 2011-07-31-8,096,927USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-10-31146,463USD
At 2011-07-31354,198USD
At 2011-07-30354,198USD
At 2010-10-3176,850USD
At 2010-07-31321,253USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-08-01 to 2011-10-311,813,364USD92
2010-08-01 to 2010-10-31-8,862,195USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-08-01 to 2011-10-31-207,735USD92
2010-08-01 to 2010-10-31-242,745USD92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-08-01 to 2011-10-310USD92
2010-08-01 to 2010-10-310USD92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-08-01 to 2011-10-310USD92
2010-08-01 to 2010-10-31-1,658USD92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-08-01 to 2011-10-310USD92
2010-08-01 to 2010-10-310USD92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-10-31-107,161,649USD
At 2011-07-31-108,975,013USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-08-01 to 2011-10-3149,823,880shares92
2010-08-01 to 2010-10-3147,317,576shares92

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2011-08-01 to 2011-10-3173,669,085shares92
2010-08-01 to 2010-10-3147,317,576shares92

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2011-08-01 to 2011-10-310.04USD/shares92
2010-08-01 to 2010-10-31-0.19USD/shares92

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2011-08-01 to 2011-10-310USD/shares92
2010-08-01 to 2010-10-31-0.19USD/shares92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-10-315,425USD
At 2011-07-317,926USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-08-01 to 2011-10-31-193,508USD92
2010-08-01 to 2010-10-31-629,096USD92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-10-31193,603USD
At 2011-07-31399,304USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-10-315,867,343USD
At 2011-07-315,748,252USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-10-31560,189USD
At 2011-07-31530,373USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-08-01 to 2011-10-31193,508USD92
2010-08-01 to 2010-10-31629,096USD92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-08-01 to 2011-10-3170,571USD92
2010-08-01 to 2010-10-31219,326USD92

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-10-31100,850,221USD
At 2011-07-31100,828,262USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2011-10-31381,826USD
At 2011-07-31379,325USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-10-310USD
At 2011-07-3111,382USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-10-31532,602USD
At 2011-07-31608,401USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-10-3135,758USD
At 2011-07-3145,106USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-08-01 to 2011-10-31122,937USD92
2010-08-01 to 2010-10-31409,770USD92

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-08-01 to 2011-10-312,501USD92
2010-08-01 to 2010-10-3111,784USD92

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-08-01 to 2011-10-312,501USD92
2010-08-01 to 2010-10-317,926USD92

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-08-01 to 2011-10-310USD92
2010-08-01 to 2011-07-31500,000USD365
2010-08-01 to 2010-10-312,600USD92

Inspect the source

Entity
TAMIR BIOTECHNOLOGY, INC. / CIK 0000708717
Captured
SEC response SHA-256
566a00c8df52e72152024fec1c9d2233cb800634c47927ab03b1326e52fe9166

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000708717.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))